Cutaneous appendage tumors: Familial cylindromatosis and associated tumors update

Advances in Dermatology

Volumn 21, Issue , 2005, Pages 217-234

  Lian, Fangru ^a   Cockerell, Clay J ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Dermpath Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29244474661     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2005.06.005     Document Type: Review

References (52)

1. Weedon D: Skin Pathology, ed 2. London, Churchill Livingstone, 2002, p 859.
2. Santa Cruz DJ: Sweet gland carcinoma: A comprehensive review. Semin Diag Pathol 4:38-74, 1987.
3. Kovalenko A, Chable-Bessia C, Cantarella G, et al: The tumor suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424:801-805, 2003.
4. Brummelkamp TR, Nijman SM, Dirac AM, et al: Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424:797-801, 2003.
5. Trompouki E, Hatzivassiliou E, Tsichritzis T, et al: CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424:793-796, 2003.
6. Freedberg IM, Eisen AZ, Wolff K, et al: Fitzpatrick's Dermatology in General Medicine, ed 6. pp 785-808, 2003.
7. Ancell H: History of a remarkable case of tumors, developed on the head and face, accompanied with a similar disease in the abdomen. Med Chri Trans R Med Chir London 25:227-246, 1842.
8. Brooke HG: Epithelioma adenoides cysticum. Br J Dermatol 4:270-285, 1892.
9. Fordyce JA: Multiple benign epithelioma of the skin. J Cutan Dis 10: 459-473, 1892.
10. Spiegler E: Tuber Endotheliome der Haut. Arch Dermatol Syphil 50: 163-176, 1899.
11. Biggs PJ, Wooster R: Familiar cylindromatosis (turban tumor syndrome) gene localized to chromosome 16q12-13: Evidence for its role as a tumor suppressor. Nat Genet 11:441-443, 1995.
12. Bignell GR, Warren W, Seal S, et al: Identification of the familiar cylindromatosis tumor-suppressor gene. Nat Genet 25:160-165, 2000.
13. Hu G, Onder M, Gill M, et al: A novel missense mutation in CYLD in family with Brooke-Spiegler syndrome. J Invest Dermatol 121:732-734, 2003.
14. Ackerman A: Neoplasms With Eccrine Differentiation. Philadelphia, Lea & Febiger, 1990.
15. Wick M: Cutaneous Adnexal Tumors: A Guide to Pathologic Diagnosis. Chicago, ASCP, 1991.
16. Hurt MA, Santa Cruz DJ: Adnexal tumors, in Fletcher CDM (ed): Diagnostic Histopathology of Tumors, ed 2. Edinburgh, Scotland, Churchill Livingstone, 2000, p 1378.
17. Gerretsen AL, Van Der Putte SC, Deenstra W, et al: Cutaneous cylindromas with malignant transformation, Cancer 72:1618-1623, 1993.
18. Gutierrez PP, Eggermann T, Holler D, et al: Phenotype diversity in familial cylindromatosis: A frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol 119:527-531, 2002.
19. Durani BK, Kurzen H, Jackel A, et al: Malignant transformation of multiple dermal cylindroma. Br J Dermatol 145:653-656, 2001.
20. Pizinger K, Michal M: Malignant cylindroma in Brooke-Spiegler syndrome. Dermatology 201:255-257, 2000.
21. Gerretsen AL, Beemer FA, Deenstra W, et al: Familal cutaneous cylindromas. Investigation in five generations of a family. J Am Acad Dermatol 133:199-206, 1995.
22. Michal M, Lamovec J, Mukensnable P, et al: Spiradenocylindroma and cylindroma in the same lesion: Report of 12 cases. Pathol Int 49:419-425, 1999.
23. Dijkhuizen T, Van den Berg E, Nikkels PG, et al: Cytogenetics of a case of eccrine spiradenoma. Hum Pathol 23:1085-1087, 1992.
24. Takata M, Quinn AG, Hashimoto K, et al: Low frequency of loss of heterozygosity at the nevoid basal cell carcinoma locus and other selected loci in appendageal tumours. J Invest Dermatol 106:1141-1144, 1996.
25. Wang C, Deng l, Hoang M, et al: Tak1 is an ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351, 2001.
26. Jono H, Lim JH, Chen LF, et al: NF-κB activation through IKK-i-dependent TRAF/TANK phosphorylation. Genes Cells 5:191-202, 2000.
27. Deng L, Wang L, Spencer E, et al: Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351-361, 2000.
28. Karin M, Cao Y, Greten FR, et al: NF-κB in cancer: From innocent by-stander to major culprit. Nature 2:301-310, 2002.
29. Sun L, Chen J: The novel functions of ubiquitination signaling. Curr Opin Cell Biol 16:119-126, 2004.
30. Wilkinson KD: Signal transduction: Aspirin, ubiquitin and cancer. Nature 424:738-739, 2003.
31. Lakhani SR: Putting the brakes on cylindromatosis? N Engl J Med 350: 187-188, 2004.
32. Sutton RL: A rare sweat gland tumor: Syringocystadenoma nodularis. Arch Dermatol 30:195-206, 1934.
33. Kersting DW, Helwig EB: Eccrine spiradenoma. Arch Dermatol 73:199, 1956.
34. Mambo NC: Eccrine spiradenoma: Clinical and pathologic study of 49 tumors. J Cutan Pathol 10:312, 1983.
35. Winkelmann RK, Wolff K: Histochemistry of hidradenoma and eccrine spiradenoma. J Invest Dermatol 49:173-180, 1967.
36. Goette DK, McConnell MA, Fowler VR: Cylindroma and eccrine spiradenoma coexistent in the same lesion. Arch Dermatol 118:273-274, 1982.
37. Moll R, Franke WW, Schiller DL, et al: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24, 1982.
38. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase. J Histochem Cytochem 32:219-229, 1984.
39. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
40. Campbell GA, Burgdorf WHC, Everett MA: The immunohistochemical localization of lysozyme in human axillary apocrine glands. J Invest Dermatol 79:351-353, 1982.
41. Cotton DW: Immunohistochemical staining of normal sweat glands. Br J Dermatol 114:441-449, 1986.
42. Noda Y, Horike H, Watanabe Y, et al: Immunohistochemical identification of epithelial membrane antigen in sweat gland tumours by the use of monoclonal antibody. Pathol Res Pract 182:797-804, 1987.
43. Egan MJ, Crocker J, Newman J, et al: Immunohistochemical localization of S100 protein in skin tumors. Arch Pathol Lab Med 110:765-767, 1986.
44. Biernat W, Wozniak L: p53 expression in sweat gland tumors. Pol J Pathol 47:3-6, 1996.
45. Campbell C: Overexpression of p53 in malignant spiradenomas. Histopathology 26:439-442, 1995.
46. Penneys NS: Immunohistochemistry of adnexal neoplasms. J Cutan Pathol 11:357-364, 1984.
47. Gray HR, Helwig EB: Epithelioma adenoids cysticum and solitary trichoepithelioma. Arch Dermatol 87:102-114, 1963.
48. Gaul LE: Heredity of multiple benign cystic epithelioma. Arch Dermatol Syphil 68:517-524, 1953.
49. Zeligman I: Solitary trichoepithelioma. Arch Dermatol 82:35-43, 1986.
50. Zhang G, Hu L, Huang W, et al: CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat 23:400, 2004.
51. Zhang XL, Liang YH, He PP, et al: Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma. J Invest Dermatol 122:658-664, 2004.
52. Salhi A, Bornholdt D, Oeffner F, et al: Multiple familial trichoepithelioma caused by mutations in the cylindromatosis tumor suppressor gene. Cancer Res 64:5113-5117, 2004.